Related LncRNAs
ID	lncRNA Name	Disease	Method	Sample	Expression pattern	Dysfunction type	Description	PMID	Source
EL0556	H19	meningioma	N/A	N/A	N/A	epigenetics	An examination of meningiomas (World Health Organization grades I-III) demonstrated more robustly that the imprinting status of H19 is perturbed with LOI in a significant number of these tumors.	20380817	LncRNADisease
EL0556	H19	meningioma	N/A	N/A	N/A	regulation	Epigenetic deregulation of lncRNAs genes is associated with disease	23791884	LncRNADisease
EL0556	H19	meningioma	qPCR etc.	meningioma tissue	differential expression	N/A	In total, 24 meningiomas of WHO grade I, II and III were analysed. 15 meningiomas (63%) were informative for the ApaI polymorphism in the IGF2 gene. Monoallelic expression (MAE) for IGF2 was found in 11 out of 15 tumours (73%) which is in contrast to the lack of imprinting status of IGF2 in leptomeninges. Ten cases (42%) were heterozygous for the H19 gene and biallelic expression was found in 3 out of 10 meningiomas (30%). These results indicate that modulation of the imprinting status of IGF2 and H19 may play an important role for the development of meningiomas.	10738131	Lnc2Cancer
EL0861	MEG3	meningioma	N/A	N/A	N/A	regulation	MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas.	23307326	LncRNADisease
EL0861	MEG3	meningioma	qPCR, Luciferase reporter assay, ISH etc.	meningioma tissue	down-regulated	epigenetics	Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression.	20179190	LncRNADisease Lnc2Cancer
EL0986	NOS2	meningioma	qPCR etc.	meningioma tissue	up-regulated	expression	anti-NOS2A is a lncRNA that is expressed in meningiomas and glioblastomas from a genomic locus that evolved by duplication of the NOS2A gene followed by internal DNA inversion.	18820242	LncRNADisease Lnc2Cancer